Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4I8I0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 164 | 168 | PF00656 | 0.494 |
CLV_C14_Caspase3-7 | 79 | 83 | PF00656 | 0.434 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.558 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.536 |
CLV_PCSK_FUR_1 | 110 | 114 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.536 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 196 | 200 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.509 |
CLV_Separin_Metazoa | 106 | 110 | PF03568 | 0.516 |
CLV_Separin_Metazoa | 68 | 72 | PF03568 | 0.520 |
DEG_APCC_DBOX_1 | 169 | 177 | PF00400 | 0.569 |
DEG_APCC_DBOX_1 | 66 | 74 | PF00400 | 0.520 |
DOC_MAPK_gen_1 | 32 | 41 | PF00069 | 0.595 |
DOC_MAPK_MEF2A_6 | 71 | 78 | PF00069 | 0.487 |
DOC_MAPK_NFAT4_5 | 71 | 79 | PF00069 | 0.488 |
DOC_PP2B_LxvP_1 | 144 | 147 | PF13499 | 0.589 |
DOC_USP7_MATH_1 | 152 | 156 | PF00917 | 0.634 |
DOC_WW_Pin1_4 | 165 | 170 | PF00397 | 0.487 |
LIG_14-3-3_CanoR_1 | 50 | 58 | PF00244 | 0.406 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.624 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.573 |
LIG_FHA_1 | 32 | 38 | PF00498 | 0.552 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.491 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.582 |
LIG_FHA_2 | 63 | 69 | PF00498 | 0.501 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.402 |
LIG_NRBOX | 69 | 75 | PF00104 | 0.529 |
LIG_PDZ_Class_2 | 195 | 200 | PF00595 | 0.476 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.537 |
LIG_TRAF2_1 | 40 | 43 | PF00917 | 0.456 |
MOD_CDK_SPK_2 | 165 | 170 | PF00069 | 0.460 |
MOD_CK1_1 | 168 | 174 | PF00069 | 0.501 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.658 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.587 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.458 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.645 |
MOD_CK2_1 | 168 | 174 | PF00069 | 0.661 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.503 |
MOD_GlcNHglycan | 10 | 14 | PF01048 | 0.597 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.439 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.644 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.390 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.653 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.625 |
MOD_GSK3_1 | 161 | 168 | PF00069 | 0.502 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.529 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.656 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.593 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.668 |
MOD_PIKK_1 | 116 | 122 | PF00454 | 0.505 |
MOD_PK_1 | 125 | 131 | PF00069 | 0.482 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.446 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.527 |
MOD_Plk_1 | 187 | 193 | PF00069 | 0.437 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.587 |
MOD_Plk_4 | 187 | 193 | PF00069 | 0.437 |
MOD_ProDKin_1 | 165 | 171 | PF00069 | 0.483 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.441 |
MOD_SUMO_rev_2 | 174 | 181 | PF00179 | 0.502 |
TRG_ER_diArg_1 | 108 | 110 | PF00400 | 0.563 |
TRG_ER_diArg_1 | 58 | 60 | PF00400 | 0.495 |
TRG_NES_CRM1_1 | 68 | 82 | PF08389 | 0.536 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVP8 | Leptomonas seymouri | 34% | 97% |
A0A3Q8ILP4 | Leishmania donovani | 100% | 100% |
A4HKZ9 | Leishmania braziliensis | 62% | 100% |
E9B3E0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q4R2 | Leishmania major | 90% | 100% |